Syndax Pharmaceuticals
SNDX
SNDX
166 hedge funds and large institutions have $1.48B invested in Syndax Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 83 increasing their positions, 42 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
3.97% less ownership
Funds ownership: 106.65% → 102.67% (-4%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
52% less call options, than puts
Call options by funds: $2.23M | Put options by funds: $4.69M
Holders
166
Holding in Top 10
7
Calls
$2.23M
Puts
$4.69M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$14.9M | |
| 3 | +$12.8M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.6M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$9.94M |
Top Sellers
| 1 | -$45.3M | |
| 2 | -$28.1M | |
| 3 | -$20.8M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$19.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$17M |